ANL 28.52 No Change ▼ 0.00 (0%)
ASC 16.68 Decreased By ▼ -0.03 (-0.18%)
ASL 23.76 Increased By ▲ 0.01 (0.04%)
AVN 94.24 Increased By ▲ 0.34 (0.36%)
BOP 9.47 No Change ▼ 0.00 (0%)
BYCO 9.56 Decreased By ▼ -0.02 (-0.21%)
DGKC 110.50 No Change ▼ 0.00 (0%)
EPCL 47.45 No Change ▼ 0.00 (0%)
FCCL 21.28 Increased By ▲ 0.13 (0.61%)
FFBL 27.97 No Change ▼ 0.00 (0%)
FFL 19.28 Increased By ▲ 0.01 (0.05%)
HASCOL 14.31 No Change ▼ 0.00 (0%)
HUBC 86.00 No Change ▼ 0.00 (0%)
HUMNL 7.30 Increased By ▲ 0.04 (0.55%)
JSCL 31.47 No Change ▼ 0.00 (0%)
KAPCO 40.73 No Change ▼ 0.00 (0%)
KEL 4.11 Increased By ▲ 0.01 (0.24%)
LOTCHEM 16.20 Increased By ▲ 0.01 (0.06%)
MLCF 43.02 No Change ▼ 0.00 (0%)
PAEL 39.86 Increased By ▲ 0.01 (0.03%)
PIBTL 12.91 Increased By ▲ 0.01 (0.08%)
POWER 11.40 No Change ▼ 0.00 (0%)
PPL 93.29 No Change ▼ 0.00 (0%)
PRL 23.80 No Change ▼ 0.00 (0%)
PTC 9.30 No Change ▼ 0.00 (0%)
SILK 1.20 No Change ▼ 0.00 (0%)
SNGP 44.33 Decreased By ▼ -0.02 (-0.05%)
TRG 108.48 No Change ▼ 0.00 (0%)
UNITY 33.15 No Change ▼ 0.00 (0%)
WTL 1.12 No Change ▼ 0.00 (0%)
BR100 4,856 Decreased By ▼ -9.94 (-0.2%)
BR30 24,724 Decreased By ▼ -96.85 (-0.39%)
KSE100 45,868 Decreased By ▼ -116.42 (-0.25%)
KSE30 19,061 Decreased By ▼ -87.18 (-0.46%)
World

Brazilian clinics to buy India's COVAXIN vaccine pending approval

  • Private sector talks to acquire Bharat's COVAXIN vaccine would not interfere with the Brazilian government's efforts to acquire vaccines for the public sector.
  • Bharat Biotech said on Tuesday that it had signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply the vaccine even though it has yet to be approved.
13 Jan 2021

SAO PAULO: Brazil's private sector vaccine clinics will be able to give customers a COVID-19 shot developed by India's Bharat Biotech once Brazil's federal health regulator has approved the drug, the head of the Brazilian Association of Vaccine Clinics (ABCVAC) said on Wednesday.

Speaking after a trip to visit Bharat Biotech executives in India, ABCVAC President Geraldo Barbosa said that private sector talks to acquire Bharat's COVAXIN vaccine would not interfere with the Brazilian government's efforts to acquire vaccines for the public sector.

Barbosa said that private clinics would only be able to buy the vaccine once health regulator Anvisa has signed off on the drug. He did not say whether a deal with Bharat had been signed, nor did he provide specific numbers on the size of any order.

Brazil's President Jair Bolsonaro is under mounting pressure because of the slow pace of the country's vaccine rollout. Inoculations have yet to begin in Latin America's largest country and Anvisa has yet to approve any vaccine for use.

Bharat Biotech said on Tuesday that it had signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply the vaccine even though it has yet to be approved.